Nuo Therapeutics, Inc. — Form D

Nuo Therapeutics, Inc. of Houston, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-05-20. The offering totals $10.5M, of which $7.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
Lawrence Eric AtinskyDirectorGaithersburg, MD
Joseph E Del GuercioDirectorGaithersburg, MD
C. ERIC WINZERDirectorROCKVILLE, MD
David JordenDirectorHouston, TX
David JordenExecutive OfficerHouston, TX
Paul Eric MintzDirectorHouston, TX
Peter ClausenExecutive OfficerHouston, TX
C Eric WinzerDirectorHouston, TX
Scott Eric PittmanDirectorHouston, TX
James P BensonDirectorDALLAS, TX
LAWRENCE S ATINSKYDirectorGAITHERSBURG, MD
PAUL D MINTZDirectorGAITHERSBURG, MD
PETER A CLAUSENExecutive OfficerGAITHERSBURG, MD
DAVID E JORDENDirectorGAITHERSBURG, MD
DAVID E JORDENExecutive OfficerGAITHERSBURG, MD
SCOTT M PITTMANDirectorGAITHERSBURG, MD
ERIC C WINZERDirectorGAITHERSBURG, MD
James S BensonDirectorKennesaw, GA
Stephen P KeithDirectorGAITHERSBURG, MD
Joseph P Del GuercioDirectorGAITHERSBURG, MD
Steven P ShallcrossExecutive OfficerGAITHERSBURG, MD
David P JordenDirectorGAITHERSBURG, MD
Mark P McLoughlinDirectorGAITHERSBURG, MD
Martin P RosendaleDirectorGAITHERSBURG, MD
Martin P RosendaleExecutive OfficerGAITHERSBURG, MD

Other filings by this issuer (15)

FiledFormOfferingSold
2025-08-04D$791K$791K
2024-09-23D$849K$849K
2024-05-22D$651K$651K
2023-12-22D$963K$963K
2023-08-08D$1.0M$1.0M
2022-05-19D$408K$408K
2022-05-06D$3.5M$3.5M
2018-06-12D$500K$500K
2013-12-10D$3.0M$3.0M
2012-02-15D$21.0M$21.0M
2011-07-26D$1.3M$1.3M
2011-07-26D$600K$600K
2011-05-04D$325K$325K
2010-10-19D$10.0M$147K
2010-04-22D$3.6M$3.6M

More